goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

ADMA Biologics Inc

ADMA · UNKNOWN

ADMA is profitable and ASCENIV is still growing, but Q1 2026 reset the story: standard IG pricing pressure, distributor timing, BIVIGAM weakness, and long-term guidance withdrawal turned 2026 into a proof year.

Ask Question
ADMAADMA Biologics IncBiopharmaceuticalsCoverage BootstrapImmunologyNASDAQ
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Latest ReportJul 22, 2026ADMA's ASCENIV Rocket Just Met the IVIG Pricing WallView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Company filters1 of 1 reports match
Clear filters
Selected tags
NasdaqCoverage Bootstrap
Clear tags
MatchAny tagAll tags
Latest Thesis

ADMA's ASCENIV Rocket Just Met the IVIG Pricing Wall

ADMA is profitable and ASCENIV is still growing, but Q1 2026 reset the story: standard IG pricing pressure, distributor timing, BIVIGAM weakness, and long-term guidance withdrawal turned 2026 into a proof year.

Jul 22, 20265 minSlides available
Read reportOpen slidesDiscussion (0)
ADMA Biologics IncADMA's ASCENIV Rocket Just Met the IVIG Pricing WallJul 22, 2026
Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Sign in to continue

Recent Reports

Compact report index for this company.

View all 1 reports ->
ReportTypeUpdatedReadActions
ADMA's ASCENIV Rocket Just Met the IVIG Pricing WallADMA is profitable and ASCENIV is still growing, but Q1 2026 reset the story: standard IG pricing pressure, distributor timing, BIVIGAM weakness, and long-term guidance withdrawal turned 2026 into a proof year.NASDAQJul 22, 20265 minReadSlides

Report Sources

No source records are attached to the current company reports.

FollowAdd to Watchlist